Navigation Links
Spine patients who quit smoking report diminished pain
Date:3/18/2013

CHICAGO Smoking is a known risk factor for back pain and disc disease. In a new study presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers reviewed smoking cessation rates and related pain in 6,779 patients undergoing treatment for spinal disorders with severe axial (spine) or radicular (leg) pain. Information on each patient's age, gender, weight, smoking history, assessment of pain, treatment type and co-morbid depression also were assessed.

Overall, 8.9 percent of patients over the age of 55 smoked compared with 23.9 percent of those aged 55 and younger. Twenty-five percent of the patients older than age 55 had quit smoking, as did 26.1 percent of those younger than age 55.

Current smokers in both age groups reported greater pain than those who had never smoked. Mean improvement in reported pain over the course of treatment was significantly different in non-smokers and current smokers in both age groups.

Those who quit smoking during the course of care reported greater pain improvement than those who continued to smoke. As a group, those who continued smoking during treatment had no clinically significant improvement in reported pain, regardless of age.


'/>"/>

Contact: Lauren Pearson Riley
pearson@aaos.org
708-227-1773
American Academy of Orthopaedic Surgeons
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. Human-like spine morphology found in aquatic eel fossil
2. Renewal grant supports genetic research into arthritis of the spine
3. Researchers in Manchester find genetic key to preventing spine tumors
4. Spinal tap -- using cactus spines to isolate DNA
5. Reproductive health providers should discuss environmental exposure risks with patients
6. Low-calorie diet may be harmful for bowel disease patients
7. Interventional radiology: Mitigating symptoms, improving quality of life of MS patients
8. Interventional radiologists see significant symptom relief in MS patients
9. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
10. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
11. Obese patients face higher radiation exposure from CT scans -- but new technology can help
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... network in Tanzania is playing a vital role in ... west in response to climate and environmental changes, according ... Using data on savannah birds from the Tanzanian Bird ... over recent decades - the researchers found that they ... move to areas further west where dry seasons are ...
(Date:6/19/2013)... the cover story for the journal Genetics ... University of Massachusetts Amherst describe a new experimental technique ... function of individual proteins in individual cell types in ... deeper insights into protein function, Chase says, "because we ... single protein does when we isolate its function in ...
(Date:6/19/2013)... Flemish plant scientist Marc Van Montagu (born 1933) is ... the American scientists Mary-Dell Chilton and Robert T. Fraley. ... the US Secretary of State, John Kerry. The World ... agriculture" - gives the award annually to one or ... importance for the quality, quantity or availability of food. ...
Breaking Biology News(10 mins):Protected areas provide African birds with stepping stones to survival 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4
... (Boston) Researchers and clinicians from Boston Medical ... than $13 million grant from the National Institutes of ... former extremely low gestational age newborns (ELGANS). The study ... MD, chief of pediatric neurology at BMC, who also ...
... The University of Utah is launching a six-year, $21.5 million ... for uses ranging from faster computers and communications devices to ... of Excellence in Materials Research and Innovation is being established ... from the National Science Foundation (NSF), $6.5 million for major ...
... Sept. 8, 2011 A team of researchers from ... Hospital (SLEH) are working to develop improved screening methods ... made its way to Texas. Specifically, the ... Klebsiella pneumoniae, which is increasingly resistant to most drugs ...
Cached Biology News:BMC awarded NIH grant to study brain abnormalities in former ELGANS patients 2$21.5 million for materials research at the University of Utah 2$21.5 million for materials research at the University of Utah 3UH researchers work to develop screening method for superbug 2
(Date:6/19/2013)... 2013 Clinverse, Inc. , ... clinical trials, today announced it will be exhibiting ... #2000) in Boston, June 24-26, 2013. Clinverse’s ... only fully configurable, cloud-based clinical financial lifecycle system. ... within Clinverse’s eClinical Commerce Network, automates site contract ...
(Date:6/19/2013)... BREA, Calif. , June 19, 2013  Continuing ... of myocardial infarction (MI), Beckman Coulter , Inc. ... clearance of its new Access AccuTnI+3 troponin I assay ... "Clinicians have depended on Beckman Coulter,s ... the new AccuTnI+3 assay has the proven performance to ...
(Date:6/19/2013)... Today DuPont Executive Vice President ... leaders in the greatest challenge facing our time – ... Borel spoke at the International Food and ... urgent need for students to contribute their time and ... and reached in collaboration with others. , “Food is ...
(Date:6/19/2013)... BioConvergence team members Curtis Strother ... 2013’s BioLogistics Summit in San Francisco earlier this ... Chain IQ and IQPC, addressed the increasingly complex ... part, attributed to current trends of globalization, outsourcing, ... trends is an increase in movement, which is ...
Breaking Biology Technology:Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2
... Beckman Coulter,Inc. (NYSE: BEC ), a leading ... and innovate complex biomedical testing,announced today that Robert ... at the Lazard Capital Markets Fourth Annual,Healthcare Conference ... (ET). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) The ...
... Mass., Nov. 19 Advanced Instruments, Inc., ... acquired 100% of the,shares of Mart Microbiology ... the,transaction were not disclosed. Mart Microbiology ... These systems create custom environments for anaerobic,bacteria ...
... MALVERN, Pa., Nov. 19 Siemens Medical ... and,healthcare systems innovate their clinical and financial ... At the 93rd Scientific Assembly and Annual ... (RSNA) from Nov. 25 to 30 at,McCormick ...
Cached Biology Technology:Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2Advanced Instruments Acquires Mart Microbiology B.V. 2Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian 2Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian 3
... Time of Flight Mass Analyzer for superior sensitivity, mass accuracy, and ... 25,000 m/z, * Precursor ion selection range: 150 - 4000 m/z, ... ppm with internal reference, * Dynamic range: 4 orders of magnitude ... ...
... is specifically designed to target and display ... cerevisiae. Displayed proteins can be analyzed for ... putative ligands. pYD1 uses the a-agglutinin yeast ... Aga1 and Aga2, to display recombinant protein ...
... Oncostatin M (OSM) is a pleiotropic cytokine ... Kaposis sarcoma cells. OSM inhibits the growth ... simulates fibroblast, smooth muscle and Kaposis sarcoma ... and low density lipoprotein receptor expression on ...
Mouse polyclonal antibody to BTAF1 - BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)...
Biology Products: